Name: Evommune, Inc. (EVMN) Balance Sheet
Creator: FinSpry

Evommune Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Evommune, Inc. (EVMN) - Annual data in millions USD
Breakdown	FY 2024	FY 2023
Period Ending	Dec 2024	Dec 2023
Current Assets
Cash and Cash Equivalents	16.25	29.02
Short-Term Investments	55.79	50.06
Cash & Short-Term Investments	72.04	79.08
Accounts Receivable	0.00	0.00
Inventory	0.00	0.00
Other Current Assets	1.95	0.95
Total Current Assets	73.99	80.03
Non-Current Assets
Property, Plant & Equipment (Net)	1.80	1.97
Long-Term Investments	0.21	0.00
Other Non-Current Assets	0.06	0.25
Total Non-Current Assets	2.07	0.00
Total Assets	76.06	82.25
Current Liabilities
Accounts Payable	8.26	1.76
Short-Term Debt	1.02	0.00
Accrued Liabilities	6.73	4.03
Deferred Revenue	3.00	0.00
Other Current Liabilities	15.70	0.30
Total Current Liabilities	27.98	6.86
Non-Current Liabilities
Long-Term Debt	192.30	0.00
Deferred Tax Liabilities	0.00	3.00
Other Non-Current Liabilities	0.02	0.25
Total Non-Current Liabilities	192.31	0.00
Total Liabilities	220.29	10.59
Stockholders' Equity
Common Stock	0.00	0.00
Retained Earnings	-152.22	-83.91
Additional Paid-in Capital	7.98	0.00
Total Stockholders' Equity	-144.24	71.66
Total Liabilities & Equity	76.06	0.00